Search clinical trials for: endocrine-modulating drug therapy

Total 18787 results

LUTRONIC Corporation

Unknown

Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema

Diabetic Macular Edema

Korea, Republic of
McMaster University
Canadian Institutes of Health Research (CIHR)

Completed

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months (DODS)

Deep Vein Thrombosis | Pulmonary Embolism

United States, Canada, Ireland, United Kingdom
Massachusetts General Hospital
Genentech, Inc.

Not yet recruiting

Atezolizumab+Bevacizumab+SBRT in Unresectable HCC

Unresectable Hepatocellular Carcinoma

United States
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...

Active, not recruiting

A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

Squamous Cell Carcinoma of the Head and Neck

United States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more
University of Sydney
Center for Eye Research Australia

Completed

Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO) (LADAMO)

Diabetic Retinopathy

Australia
Dr. Rita Bertuetti
Cambridge University Hospitals NHS Foundation Trust

Unknown

Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage (TIRASH)

Thyroid Disfunction | Subarachnoid Haemorrhage From Cerebral Aneurism Rupture | Pituitary Disfunction
wang shusen

Recruiting

Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

Breast Cancer

China
Military Institute of Medicine, Poland

Unknown

Triple Therapy for Diffuse Diabetic Macular Edema (TTDDME)

Diffuse Diabetic Macular Edema

Poland
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Shock, Cardiogenic
Baylor Breast Care Center
GlaxoSmithKline

Completed

Lapatinib and Trastuzumab With or Without Endocrine Therapy

Breast Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

Ovarian Cancer

United States
Yin-ku Lin
Chang Gung University

Completed

Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating Psoriasis

Nail Psoriasis

Taiwan
University of Sao Paulo

Completed

Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy

Cardiovascular Diseases | Vascular Diseases | Eye Diseases | Diabetic Angiopathies | Retinal Diseases | Diabetic Retinopathy

Brazil
Novartis Pharmaceuticals

Completed

RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity (RAINBOW)

Retinopathy of Prematurity

United States, Austria, Belgium, Croatia, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Hungary, India, Italy, Japan, Lithuania, Malaysia, Mexico, Poland, Romania, Russian Federation, Saudi Arabia, Slovakia, Taiwan, Turkey, United...
University of Zurich

Completed

Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma (ARTE)

Glioblastoma

Switzerland
Ural State Medical University
Ural Institute of Cardiology; De Haar Research Foundation

Terminated

Ranibizumab and the Risk of Arterial Thromboembolic Events (RATE)

Coronary Artery Disease | Cerebrovascular Disorders | Age-related Macular Degeneration

Netherlands, Russian Federation
Pfizer

Terminated

A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema

Macular Edema, Diabetic

United States, Israel, Germany, Hungary, Bulgaria, Czech Republic, Moldova, Republic of, Poland, Romania
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Shanghai East Hospital
Jinan Central Hospital; Ningbo No. 1 Hospital; Shanghai 6th People's Hospital; Shanghai... and other collaborators

Completed

One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China (OPTIMISTIC)

Ischemic Stroke

China
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases

United States
Singapore National Eye Centre
National University Hospital, Singapore; Tan Tock Seng Hospital

Active, not recruiting

Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment

Polypoidal Choroidal Vasculopathy

Singapore
Takeda

Recruiting

An Additional Analysis of Data From the PARADIGM Exploratory Study (NCT02394834) in Patients With Advanced/Recurrent Colorectal Cancer

Colorectal Cancer

Japan
Gruppo Italiano Carcinoma Renale

Unknown

Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

Italy
University Hospital Inselspital, Berne
Novartis

Completed

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

Age Related Macular Degeneration

Switzerland
Bristol-Myers Squibb

Completed

Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer (CheckMate 7FL)

Breast Cancer

China, Russian Federation, United States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Hong Kong, Ireland, Korea, Republic of, Mexico, Netherlands, Poland, Portuga... and more
Leo W. Jenkins Cancer Center
Genentech, Inc.

Withdrawn

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

Cervical Cancer

United States
Massachusetts General Hospital
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Bevacizumab and Radiation Therapy for Sarcomas

Soft Tissue Sarcoma | Leiomyosarcoma | Fibrosarcoma | Liposarcoma | Synovial Sarcoma | Fibrous Histiocytoma

United States
UMC Utrecht

Not yet recruiting

Systemic Therapy in Combination With Stereotactic Radiotherapy in Patients With Metastatic Colorectal Cancer up to 10 Metastatic Sites (SIRIUS)

Metastatic Colorectal Cancer | Oligometastatic Disease

Netherlands
National Cancer Institute (NCI)

Withdrawn

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage II Pancreatic Cancer | Stage I Pancreatic Cancer
University of Florida

Completed

Fibrinolytic Therapy Versus Medical Thoracoscopy

Pleural Diseases

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Azienda Ospedaliero-Universitaria Careggi
University of Florence

Recruiting

ExclUsive endocRine Therapy Or Partial Breast Irradiation for Women Aged ≥70 Years Early Stage Breast Cancer (EUROPA)

Breast Cancer

Italy
Ciusss de L'Est de l'Île de Montréal
Juvenile Diabetes Research Foundation; Institut de Recherches Cliniques de...

Completed

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes

Type 1 Diabetes | Exocrine Pancreatic Insufficiency

Canada
The First Affiliated Hospital with Nanjing Medical...

Unknown

the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy

Coronary Atherosclerosis

China
Association for Innovation and Biomedical Research...
European Vision Institute Clinical Research Network

Completed

Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy (ATLANTIC)

Polypoidal Choroidal Vasculopathy

Portugal, Spain
Illinois Retina Associates
Novartis Pharmaceuticals

Completed

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment (CLOVER)

Age-Related Macular Degeneration

United States
Ottawa Hospital Research Institute

Completed

Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT) (REaCT-RETT)

Early-stage Breast Cancer

Canada
Karolinska Institutet
The Swedish Society of Medicine; The Swedish Breast Cancer Association (BRO); Swedish Breast Cancer Group

Completed

Prognostic and Predictive Factors for Small Breast Tumors

Breast Cancer

Sweden
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Cephalon

Completed

A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer (ABCSG 32)

Breast Cancer

Austria
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain Tumor

United States
California Retina Consultants
Novartis

Completed

Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)

Macular Edema | Age Related Macular Degeneration | Choroidal Neovascularization

United States
Barts and the London School of Medicine and Dentistry

Completed

Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Kidney Cancer

United Kingdom
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Veno-occlusive Disease

United States, Canada
Usona Institute
Worldwide Clinical Trials

Recruiting

Psilocybin for Major Depressive Disorder (MDD) (uAspire)

Depressive Disorder, Major

United States
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Early Assessment of Impaired Cardiac Function in Patients With Diabetes Mellitus

Diabetes Mellitus | Left Ventricular Dysfunction

China
Asan Medical Center

Completed

Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Korea, Republic of
University of Miami

Recruiting

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

Recurrent Glioblastoma

United States
Vitreous -Retina- Macula Consultants of New York
QLT Inc.

Terminated

Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD

Macular Degeneration

United States
University of Palermo

Completed

Rehabilitative Therapy and Pridinol in Patients With Lumbar Spondylarthrosis and Chronic Low Back Pain

Spondyloarthropathy

Italy
University of British Columbia

Completed

Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab.

Macular Degeneration

Canada

Search clinical trials for: endocrine-modulating drug therapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations